Nektar Reports that Partner Affymax Has Announced FDA Approval of OMONTYSÂ Peginesatide Injection for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis

SAN FRANCISCO March 28 2012 PRNewswire Nektar Therapeutics NASDAQ NKTR today reported that its partner Affymax Inc. announced that the U.S. Food and Drug Administration FDA has approved OMONTYS&174; peginesatide Injection for the treatment of anemi...